Assessing the Effectiveness of Psychiatric Interventions on the Inpatient Unit

Launched by STANFORD UNIVERSITY · Aug 7, 2018

Keywords

ClinConnect Summary

This Stanford University study is watching how well three treatments work for people on the psychiatric inpatient unit who have depressive symptoms or suicidal thoughts. It’s an observational study, meaning researchers observe real-world outcomes after people receive one of three interventions: accelerated theta burst stimulation to the left dorsolateral prefrontal cortex (Left DLPFC aTBS), accelerated theta burst stimulation to the anterior cingulate cortex (ACC aTBS), or electroconvulsive therapy (ECT). The main goal is to see how depressive symptoms change over time and how safe and acceptable these treatments are in everyday care.

Who can join? Adults 18 and older who are admitted to Stanford Hospital’s psychiatric unit for depressive symptoms or suicidal ideation and who have received one of the three listed interventions. There are no other listed exclusion criteria. After discharge, participants will be followed for up to 6 months, with weekly mood and symptom check-ins for the first 4 weeks and then every two weeks up to 24 weeks. They’ll complete several assessments of depression and suicidal thoughts (for example, MADRS and SSI) plus other mood and sleep measures, and researchers will track medication changes and any hospital readmissions. The study, which started in 2018, aims to enroll about 200 people and will not share individual data.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Received an intervention on the psychiatric inpatient unit at Stanford Hospital aimed at treating a major depressive episode or suicidal ideation
• Exclusion Criteria:
• • -None